1. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)

   • Biyan Nathanael Harapan
   • Hyeon Joo Yoo

   Review Open access 23 January 2021 Pages: 3059 - 3071

2. SARS-CoV-2 infection in patients with primary central nervous system lymphoma

   • Alice Laurenge
   • Renata Ursu
   • Mehdi Touat

   Original Communication 02 January 2021 Pages: 3072 - 3080

   

3. COVID-19 in children with neuromuscular disorders

   • Daniel Natera-de Benito
   • Sergio Aguilera-Albesa
   • Neuromuscular Working Group of Spanish Pediatric Neurology Society

   Original Communication 02 January 2021 Pages: 3081 - 3085

4. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

   • Vardan Nersesjan
   • Moshgan Amiri
   • Daniel Kondziella

   Original Communication Open access 13 January 2021 Pages: 3086 - 3104

   

5. Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data

   • R. Beyrouti
   • J. G. Best
   • D. J. Werring

   Original Communication Open access 05 February 2021 Pages: 3105 - 3115

   

6. Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms

   • V. A. Blanco-Palmero
   • F. J. Azcárate-Díaz
   • J. González de la Aleja

   Original Communication 19 February 2021 Pages: 3116 - 3124

   

7. Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19

   • Ulrich Hofstadt-van Oy
   • Slobodan Stankovic
   • Ulrich Cleff

   Short Commentary 04 February 2021 Pages: 3125 - 3128

   

8. COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy

   • Eveline Van Looy
   • Len Veenker
   • Harald De Cauwer

   Letter to the Editors 19 February 2021 Pages: 3129 - 3131

   

9. COVID-19 in multiple sclerosis patients treated with dimethyl fumarate

   • Fioravante Capone
   • Elisabetta Ferraro
   • Vincenzo Di Lazzaro

   Letter to the Editors 20 February 2021 Pages: 3132 - 3134

10. Levodopa challenge test: indications, protocol, and guide

    • Gerard Saranza
    • Anthony E. Lang

    Review 24 April 2020 Pages: 3135 - 3143

11. Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature

    • Elisabetta Sarasso
    • Federica Agosta
    • Massimo Filippi

    Review 06 May 2020 Pages: 3144 - 3179

    

12. A review of mobile stroke units

    • Jennifer Harris

    Review 18 May 2020 Pages: 3180 - 3184

13. Expansion of the dimensions in the current management of acute ischemic stroke

    • Preeti Malik
    • Arsalan Anwar
    • Urvish Patel

    Review 20 May 2020 Pages: 3185 - 3202

14. When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis

    • Luca Marsili
    • Joaquin A. Vizcarra
    • Alberto J. Espay

    Review 20 May 2020 Pages: 3203 - 3211

    

15. Neurofilaments in progressive multiple sclerosis: a systematic review

    • Thomas Williams
    • Henrik Zetterberg
    • Jeremy Chataway

    Review Open access 23 May 2020 Pages: 3212 - 3222

    

16. Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression

    • Luca Prosperini
    • Valentina Tomassini
    • Claudio Marcello Solaro

    Review 23 May 2020 Pages: 3223 - 3237

    

17. Association between Helicobacter Pylori infection and stroke: a meta-analysis of 273,135 patients

    • Mohamed Fahmy Doheim
    • Ahmad Amr Altaweel
    • Ameer E. Hassan

    Review 23 May 2020 Pages: 3238 - 3248

    

18. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management

    • Simona Toscano
    • Salvatore Lo Fermo
    • Mario Zappia

    Review 27 May 2020 Pages: 3249 - 3268

    

19. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment

    • Lumei Kang
    • Yuyang Tian
    • Hongping Chen

    Review 30 May 2020 Pages: 3269 - 3282

    

20. 5-Year health-related quality of life outcome in patients with idiopathic normal pressure hydrocephalus

    • A. Junkkari
    • H. Sintonen
    • V. Leinonen

    Original Communication Open access 02 March 2021 Pages: 3283 - 3293

    

21. Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients

    • Jakob Rath
    • Gudrun Zulehner
    • Fritz Zimprich

    Original Communication Open access 02 March 2021 Pages: 3294 - 3300

    

22. Transient global amnesia does not increase the risk of subsequent ischemic stroke: a propensity score-matched analysis

    • Aayushi Garg
    • Kaustubh Limaye
    • Enrique C. Leira

    Original Communication 02 March 2021 Pages: 3301 - 3306

    

23. Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone

    • Eugenio Distaso
    • Giammarco Milella
    • Isabella Laura Simone

    Original Communication Open access 02 March 2021 Pages: 3307 - 3315

    

24. The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple sclerosis

    • Simone Hjæresen
    • Tobias Sejbaek
    • Åsa Fex Svenningsen

    Original Communication 04 March 2021 Pages: 3316 - 3324

    

25. Diagnostic yield of cerebrospinal fluid analysis in status epilepticus: an 8-year cohort study

    • Tolga D. Dittrich
    • Sira M. Baumann
    • Raoul Sutter

    Original Communication Open access 05 March 2021 Pages: 3325 - 3336

    

26. Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohort

    • Solveig Montaut
    • Nadège Diedhiou
    • Christine Tranchant

    Original Communication 05 March 2021 Pages: 3337 - 3343

    

27. Effect of leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year

    • Min-Gu Kang
    • Dae-Won Gwak
    • Jin-Sung Park

    Original Communication 06 March 2021 Pages: 3344 - 3351

    

28. Late-onset MS is associated with an increased rate of reaching disability milestones

    • Mads Albrecht Andersen
    • Mathias Due Buron
    • Melinda Magyari

    Original Communication 07 March 2021 Pages: 3352 - 3360

    

29. Prognostic models for amyotrophic lateral sclerosis: a systematic review

    • Lu Xu
    • Bingjie He
    • Shengfeng Wang

    Original Communication 10 March 2021 Pages: 3361 - 3370

    

30. Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders

    • Ana Marques
    • Daniel Roquet
    • Simon J. G. Lewis

    Original Communication 11 March 2021 Pages: 3371 - 3380

    

31. New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ₁₀ deficiency in muscle or skin fibroblasts

    • Serena Mero
    • Leonardo Salviati
    • Maria Marchese

    Original Communication 11 March 2021 Pages: 3381 - 3389

    

32. Eye movement alterations in presymptomatic C9orf72 expansion gene carriers

    • Anna Behler
    • Antje Knehr
    • Jan Kassubek

    Original Communication Open access 11 March 2021 Pages: 3390 - 3399

    

33. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes

    • Andrea Horta-Barba
    • Javier Pagonabarraga
    • Jaime Kulisevsky

    Original Communication 11 March 2021 Pages: 3400 - 3408

34. Diffusion tensor imaging analysis in three progressive supranuclear palsy variants

    • Jennifer L. Whitwell
    • Nirubol Tosakulwong
    • Keith A. Josephs

    Original Communication 12 March 2021 Pages: 3409 - 3420

    

35. Fall prediction in neurological gait disorders: differential contributions from clinical assessment, gait analysis, and daily-life mobility monitoring

    • Roman Schniepp
    • Anna Huppert
    • Max Wuehr

    Original Communication Open access 13 March 2021 Pages: 3421 - 3434

36. Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson’s disease

    • Heidrun H. Krämer
    • Cora Rebhorn
    • Frank Birklein

    Original Communication Open access 13 March 2021 Pages: 3435 - 3443

    

37. Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease

    • Mattia Siciliano
    • Lugi Trojano
    • Alessandro Tessitore

    Original Communication Open access 15 March 2021 Pages: 3444 - 3455

    

38. The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients

    • Roderick P. P. W. M. Maas
    • Sven Killaars
    • Dennis J. L. G. Schutter

    Original Communication Open access 20 March 2021 Pages: 3456 - 3466

    

39. Diagnostic value of video-oculography in progressive supranuclear palsy: a controlled study in 100 patients

    • Jessica Wunderlich
    • Anna Behler
    • Jan Kassubek

    Original Communication Open access 21 March 2021 Pages: 3467 - 3475

    

40. A solution to PET brain motion artefact

    • Kevin M. Bradley
    • Timothy W. Deller
    • Daniel R. McGowan

    Letter to the Editors 06 June 2021 Pages: 3476 - 3477

    

41. Correction to: A solution to PET brain motion artefact

    • Kevin M. Bradley
    • Timothy W. Deller
    • Daniel R. McGowan

    Correction 14 June 2021 Pages: 3478 - 3479

    

42. Cerebrovascular manifestations in hematological diseases: an update

    • José M. Ferro
    • Joana Infante

    Neurological Update Open access 13 February 2021 Pages: 3480 - 3492

    

43. Huntington’s disease: lessons from prion disorders

    • Melanie Alpaugh
    • Francesca Cicchetti

    Neurological Update 24 February 2021 Pages: 3493 - 3504

44. Medication-overuse headache: causes, consequences and management

    • Thomas H. Massey
    • Neil P. Robertson

    Journal club Open access 05 August 2021 Pages: 3505 - 3507

45. Siegmund Erben (1863–1942)

    • Lazaros C. Triarhou

    Pioneers in Neurology 18 November 2020 Pages: 3508 - 3509

    

46. Jakub Rothfeld-Rostowski (1884–1971)

    • Jarosław Sak
    • Antoni Niedzielski
    • Magdalena Suchodolska

    Pioneers in Neurology 03 January 2021 Pages: 3510 - 3511

    

47. William Gordon Lennox (1884–1960)

    • Mattia Rosso
    • Duong Chu
    • Jonathan D. Santoro

    Pioneers in Neurology 08 January 2021 Pages: 3512 - 3513

    

48. Bernhard Dattner (1887–1952)

    • Lazaros C. Triarhou

    Pioneers in Neurology 30 January 2021 Pages: 3514 - 3516